Alzheimer’s Drugs Are a Ray of Hope

There are now two impressive possible treatments for this form of dementia. But concerns remain over cost and potential side-effects. A new drug, called donanemab, showed promising results in phase-3 trials at slowing down the decline in cognitive functions and reducing the deterioration in the ability to undertake daily tasks independently.